Cardiovascular risk factors in children after repeat doses of antenatal glucocorticoids: An RCT

Pediatrics

Volumn 135, Issue 2, 2015, Pages e405-e415

  McKinlay, Christopher J D ^a   Cutfield, Wayne S ^a   Battin, Malcolm R ^b   Dalziel, Stuart R ^c   Crowther, Caroline A ^a,d   Harding, Jane E ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; PLACEBO; BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY COMPOSITION; CARDIOVASCULAR RISK; CHILD; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; FETUS; FOLLOW UP; GESTATIONAL AGE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN SENSITIVITY; KIDNEY FUNCTION; MALE; PREMATURE LABOR; PRENATAL EXPOSURE; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; STEROID THERAPY; SURVIVOR; SYSTOLIC BLOOD PRESSURE; ADIPOSE TISSUE; ANALOGS AND DERIVATIVES; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; INFANT; INFANT, PREMATURE, DISEASES; INSULIN RESISTANCE; INTRAMUSCULAR DRUG ADMINISTRATION; LONGITUDINAL STUDY; MULTICENTER STUDY; NEWBORN; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PRESCHOOL CHILD; RISK FACTOR;

ADIPOSE TISSUE; BETAMETHASONE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INJECTIONS, INTRAMUSCULAR; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 84922655984     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-2408     Document Type: Article

References (64)

1. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;(3):CD004454. doi:10.1002/14651858.CD004454.pub2
2. Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS; Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet. 2006;367(9526):1913-1919
3. Crowther CA, McKinlay CJD, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Sys Rev. 2011;(6):CD003935. doi:10.1002/14651858.CD003935.pub3
4. Barker DJP. The developmental origins of well-being. Philos Trans R Soc Lond B Biol Sci. 2004;359(1449):1359-1366
5. Seckl JR, Holmes MC. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal " programming " of adult pathophysiology. Nat Clin Pract Endocrinol Metab. 2007;3(6):479-488
6. Dalziel SR, Walker NK, Parag V, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet. 2005;365(9474):1856-1862
7. Dessens AB, Haas HS, Koppe JG. Twenty-year follow-up of antenatal corticosteroid treatment. Pediatrics. 2000;105(6):E77
8. de Vries A, Holmes MC, Heijnis A, et al. Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function. J Clin Invest. 2007;117(4):1058-1067
9. Nyirenda MJ, Welberg LA, Seckl JR. Programming hyperglycaemia in the rat through prenatal exposure to glucocorticoids-fetal effect or maternal influence? J Endocrinol. 2001;170(3):653-660
10. Sloboda DM, Moss TJM, Li S, et al. Hepatic glucose regulation and metabolism in adult sheep: effects of prenatal betamethasone. Am J Physiol Endocrinol Metab. 2005;289(4):E721-E728
11. Crowther CA, Doyle LW, Haslam RR, Hiller JE, Harding JE, Robinson JS; ACTORDS Study Group. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357(12):1179-1189
12. Battin M, Bevan C, Harding J. Growth in the neonatal period after repeat courses of antenatal corticosteroids: data from the ACTORDS randomised trial. Arch Dis Child Fetal Neonatal Ed. 2012;97(2):F99-105
13. Battin MR, Bevan C, Harding JE. Repeat doses of antenatal steroids and hypothalamic-pituitary-adrenal axis (HPA) function. Am J Obstet Gynecol. 2007;197(1):40.e1-6
14. Mildenhall L, Battin M, Bevan C, Kuschel C, Harding JE. Repeat prenatal corticosteroid doses do not alter neonatal blood pressure or myocardial thickness: randomized, controlled trial. Pediatrics. 2009;123(4). Available at: www.pediatrics.org/cgi/content/full/123/4/e646
15. Cutfield WS, Bergman RN, Menon RK, Sperling MA. The modified minimal model: application to measurement of insulin sensitivity in children. J Clin Endocrinol Metab. 1990;70(6):1644-1650
16. Bergman RN. Lilly Lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 1989;38(12):1512-1527
17. Soergel M, Kirschstein M, Busch C, et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr. 1997;130(2):178-184
18. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F; German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens. 2002;20(10):1995-2007
19. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med. 1992; 11(10):1305-1319
20. Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4(11):1832-1843
21. Wells JC, Victora CG. Indices of wholebody and central adiposity for evaluating the metabolic load of obesity. Int J Obes (Lond). 2005;29(5):483-489
22. Wapner RJ, Sorokin Y, Thom EA, et al National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol. 2006; 195(3):633-642
23. Singh AS, Mulder C, Twisk JW, van Mechelen W, Chinapaw MJ. Tracking of childhood overweight into adulthood: a systematic review of the literature. Obes Rev. 2008;9(5):474-488
24. Goulding A, Taylor RW, Jones IE, Lewis-Barned NJ, Williams SM. Body composition of 4- and 5-year-old New Zealand girls: a DXA study of initial adiposity and subsequent 4-year fat change. Int J Obes Relat Metab Disord. 2003;27(3):410-415
25. Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and metaregression analysis. Circulation. 2008;117(25):3171-3180
26. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Kieltyka L, Berenson GS. Utility of childhood glucose homeostasis variables in predicting adult diabetes and related cardiometabolic risk factors: the Bogalusa Heart Study. Diabetes Care. 2010;33(3):670-675
27. Thearle MS, Bunt JC, Knowler WC, Krakoff J. Childhood predictors of adult acute insulin response and insulin action. Diabetes Care. 2009;32(5):938-943
28. Raitakari OT, Juonala M, Kähönen M, et al. Cardiovascular risk factors in childhood and carotid artery intimamedia thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290(17):2277-2283
29. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation. 2001;104(23):2815-2819
30. Mahoney LT, Burns TL, Stanford W, et al. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol. 1996;27(2):277-284
31. Barker DJ, Osmond C, Kajantie E, Eriksson JG. Growth and chronic disease: findings in the Helsinki Birth Cohort. Ann Hum Biol. 2009;36(5):445-458
32. Williams SM, Goulding A. Patterns of growth associated with the timing of adiposity rebound. Obesity (Silver Spring). 2009;17(2):335-341
33. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992;340(8825):925-929
34. Hofman PL, Regan F, Jackson WE, et al. Premature birth and later insulin resistance. N Engl J Med. 2004;351(21):2179-2186
35. Hofman PL, Cutfield WS, Robinson EM, et al. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab. 1997;82(2): 402-406
36. Veening MA, Van Weissenbruch MM, Delemarre-Van De Waal HA. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab. 2002;87(10):4657-4661
37. Norris SA, Osmond C, Gigante D, et al; COHORTS Group. Size at birth, weight gain in infancy and childhood, and adult diabetes risk in five low- or middle-income country birth cohorts. Diabetes Care. 2012;35(1):72-79
38. Jones A, Godfrey KM, Wood P, Osmond C, Goulden P, Phillips DIW. Fetal growth and the adrenocortical response to psychological stress. J Clin Endocrinol Metab. 2006;91(5):1868-1871
39. Bonamy AK, Martin H, Jörneskog G, Norman M. Lower skin capillary density, normal endothelial function and higher blood pressure in children born preterm. J Intern Med. 2007;262(6):635-642
40. Labayen I, Ruiz JR, Vicente-Rodríguez G, et al Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) Study Group. Early life programming of abdominal adiposity in adolescents: the HELENA Study. Diabetes Care. 2009;32(11):2120-2122
41. American Diabetes Association. Consensus Development Conference on Insulin Resistance. 5-6 November, 1997. Diabetes Care. 1998;21(2):310-314
42. Li Z, Snieder H, Harshfield GA, Treiber FA, Wang X. A 15-year longitudinal study on ambulatory blood pressure tracking from childhood to early adulthood. Hypertens Res. 2009;32(5):404-410
43. Sorof JM, Cardwell G, Franco K, Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 2002;39(4):903-908
44. Dulloo AG, Jacquet J, Solinas G, Montani JP, Schutz Y. Body composition phenotypes in pathways to obesity and the metabolic syndrome. Int J Obes (Lond). 2010;34(Suppl 2):S4-S17
45. Lauer RM, Clarke WR. Childhood risk factors for high adult blood pressure: the Muscatine Study. Pediatrics. 1989;84(4):633-641
46. Bayrakci US, Schaefer F, Duzova A, Yigit S, Bakkaloglu A. Abnormal circadian blood pressure regulation in children born preterm. J Pediatr. 2007;151(4):399-403
47. Jefferies CA, Hofman PL, Knoblauch H, Luft FC, Robinson EM, Cutfield WS. Insulin resistance in healthy prepubertal twins. J Pediatr. 2004;144(5):608-613
48. Fowden AL, Li J, Forhead AJ. Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance? Proc Nutr Soc. 1998;57(1):113-122
49. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet. 1993;341(8841):339-341
50. Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest. 1998;101(10):2174-2181
51. Lindsay RS, Lindsay RM, Waddell BJ, Seckl JR. Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone. Diabetologia. 1996;39(11):1299-1305
52. Lindsay RS, Lindsay RM, Edwards CR, Seckl JR. Inhibition of 11-betahydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension. 1996;27(6):1200-1204
53. Norberg H, Stalnacke J, Nordenström A, Norman M. Repeat antenatal steroid exposure and later blood pressure, arterial stiffness, and metabolic profile. J Pediatr. 2013;163(3):711-716
54. Finken MJ, Keijzer-Veen MG, Dekker FW, et al; Dutch POPS-19 Collaborative Study Group. Antenatal glucocorticoid treatment is not associated with longterm metabolic risks in individuals born before 32 weeks of gestation. Arch Dis Child Fetal Neonatal Ed. 2008;93(6):F442-F447
55. de Vries WB, Karemaker R, Mooy NF, et al. Cardiovascular follow-up at school age after perinatal glucocorticoid exposure in prematurely born children: perinatal glucocorticoid therapy and cardiovascular follow-up. Arch Pediatr Adolesc Med. 2008;162(8):738-744
56. Doyle LW, Ford GW, Davis NM, Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci (Lond). 2000;98(2):137-142
57. Kelly BA, Lewandowski AJ, Worton SA, et al. Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolism. Pediatrics. 2012;129(5):e1282-e1290
58. Nyirenda MJ, Carter R, Tang JI, et al. Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1. Diabetes. 2009;58(12):2873-2879
59. Langley-Evans SC, Bellinger L, McMullen S. Animal models of programming: early life influences on appetite and feeding behaviour. Matern Child Nutr. 2005;1(3):142-148
60. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115(3). Available at: www.pediatrics.org/cgi/content/full/115/3/e290
61. Mericq V, Iñiguez G, Bazaes R, et al. Differences in body composition and energy expenditure in prepubertal children born term or preterm appropriate or small for gestational age. J Pediatr Endocrinol Metab. 2009;22(11):1041-1050
62. Murphy KE, Hannah ME, Willan AR, et al; MACS Collaborative Group. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet. 2008;372(9656):2143-2151
63. Guinn DA, Atkinson MW, Sullivan L, et al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial. JAMA. 2001;286(13):1581-1587
64. Asztalos EV, Murphy KE, Willan AR, et al; MACS-5 Collaborative Group. Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr. 2013;167(12):1102-1110